previous compound ID: 307 next compound
InChIKey: CAHGCLMLTWQZNJ-BQNIITSRSA-N
SMILES: C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"E Matthes" "D Rotin" "GW Carlile" "SD Macknight" "JW Hanrahan" "DY Thomas" "J Goepp" "R Robert" "B Kus" "J Liao"

chemical graph of compound 307




CID is 246983
synonyms found at PubChem are:
lanosterol, 79-63-0, Lanosterin, Lanster, Botalan base 138, Lanosta-8,24-dienol, Lanosta-8,24-dien-3beta-ol, UNII-1J05Z83K3M, NSC60677, (3beta)-lanosta-8,24-dien-3-ol, Botalan base, CHEBI:16521, CAHGCLMLTWQZNJ-BQNIITSRSA-N, Lanosta-8,24-dien-3.beta.-ol, 1J05Z83K3M, MFCD00021108, Lanostadien-3-beta-ol, NSC 60677, Lanosta-8,24-dien-3-ol, (3beta)-, Lanosta-8,24-dien-3-ol, Lanosta-8,24-dien-3-ol, (3.beta.)-, Lanosta-8,24-dien-3-beta-ol, 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol, EINECS 201-214-9, Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-, (3-beta)-Lanosta-8,24-dien-3-ol, BRN 2226449, (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol, AI3-23643, Lanostereol, Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3beta,5alpha)-, (3.beta.)-Lanosta-8,24-dien-3-ol, Lanosta-8,24-dien-3-ol, (3-beta)-, lanosterol 50-60%, AC1L6JAE, D0P4PQ, 8,24-Lanostadien-3beta-ol, Lanosta-8, (3.beta.)-, 8,24-Lanostadien-3|A-ol, Lanosterol, >=93%, powder, SCHEMBL145834, CHEMBL225111, GTPL2746, DTXSID1040744, 3|A-Hydroxy-8,24-lanostadiene, 3beta-Hydroxy-8,24-lanostadiene, MolPort-000-146-138, ZINC3870056, LMST01010017, NSC-60677, (3 beta)-Lanosta-8,24-dien-3-ol, AKOS024307002, DB03696, Lanosta-8,24-dien-3beta-ol (8CI), MCULE-6692951185, NCGC00164398-01, (3beta,20R)-Lanosta-8,24-dien-3-ol, FT-0627682, 7073-EP2277507A1, 7073-EP2286795A1, 7073-EP2298776A1, C01724, (3alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol, (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol, 4,4,14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol, C4CA2F34-1C1A-4673-AC43-E547708CB228, Cholesta-8, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-, UNII-U431865SO1 component CAHGCLMLTWQZNJ-BQNIITSRSA-N, (3beta,5alpha)-4,4,14-trimethyl-Cholesta-8,24-dien-3-ol, (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol, (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol